心血管成像中的人工智能和深度学习:从风险分层到精确表型。

IF 8.8 1区 医学 Q1 HEMATOLOGY
Kaiyue Diao, Jiahua Lu, Alexander Dimitrakakis, Zelong Liu, Zahi A Fayad, Hao-Chih Lee, Xueyan Mei
{"title":"心血管成像中的人工智能和深度学习:从风险分层到精确表型。","authors":"Kaiyue Diao, Jiahua Lu, Alexander Dimitrakakis, Zelong Liu, Zahi A Fayad, Hao-Chih Lee, Xueyan Mei","doi":"10.1161/ATVBAHA.126.324762","DOIUrl":null,"url":null,"abstract":"<p><p>Cardiovascular imaging plays a central role in the diagnosis, risk stratification, and management of cardiovascular disease, yet the complexity and volume of imaging data increasingly exceed the capacity of conventional interpretation. Artificial intelligence (AI) and deep learning offer new tools to extract quantitative, prognostic, and phenotypic information from routine cardiovascular images. This review summarizes the fundamentals of AI and deep learning, including model architectures, training strategies, and their relevance to cardiovascular imaging, followed by a focused discussion of current applications across chest radiography, chest computed tomography, computed tomography angiography/cardiac computed tomography, cardiac magnetic resonance imaging, echocardiography, and nuclear cardiology imaging. Studies were selected with emphasis on original investigations, large cohort analyses, and external validation studies reflecting current applications of AI in cardiovascular risk stratification and precision phenotyping. Across these modalities, AI applications in automated image processing and analysis have become relatively mature. Multiple multicenter and real-world studies have validated their value in improving efficiency and supporting cardiovascular management. Approaches that move beyond conventional human-defined imaging metrics to infer cardiovascular risk and disease phenotype remain at an earlier stage, requiring further standardization, validation, and clinical evaluation. AI is expanding the role of cardiovascular imaging from visual interpretation toward integrated assessment for risk stratification and precision phenotyping, though further work is needed to confirm generalizability and real-world performance before these tools can guide individual patient management.</p>","PeriodicalId":8401,"journal":{"name":"Arteriosclerosis, Thrombosis, and Vascular Biology","volume":" ","pages":""},"PeriodicalIF":8.8000,"publicationDate":"2026-10-15","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"AI and Deep Learning in Cardiovascular Imaging: From Risk Stratification to Precision Phenotyping.\",\"authors\":\"Kaiyue Diao, Jiahua Lu, Alexander Dimitrakakis, Zelong Liu, Zahi A Fayad, Hao-Chih Lee, Xueyan Mei\",\"doi\":\"10.1161/ATVBAHA.126.324762\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p><p>Cardiovascular imaging plays a central role in the diagnosis, risk stratification, and management of cardiovascular disease, yet the complexity and volume of imaging data increasingly exceed the capacity of conventional interpretation. Artificial intelligence (AI) and deep learning offer new tools to extract quantitative, prognostic, and phenotypic information from routine cardiovascular images. This review summarizes the fundamentals of AI and deep learning, including model architectures, training strategies, and their relevance to cardiovascular imaging, followed by a focused discussion of current applications across chest radiography, chest computed tomography, computed tomography angiography/cardiac computed tomography, cardiac magnetic resonance imaging, echocardiography, and nuclear cardiology imaging. Studies were selected with emphasis on original investigations, large cohort analyses, and external validation studies reflecting current applications of AI in cardiovascular risk stratification and precision phenotyping. Across these modalities, AI applications in automated image processing and analysis have become relatively mature. Multiple multicenter and real-world studies have validated their value in improving efficiency and supporting cardiovascular management. Approaches that move beyond conventional human-defined imaging metrics to infer cardiovascular risk and disease phenotype remain at an earlier stage, requiring further standardization, validation, and clinical evaluation. AI is expanding the role of cardiovascular imaging from visual interpretation toward integrated assessment for risk stratification and precision phenotyping, though further work is needed to confirm generalizability and real-world performance before these tools can guide individual patient management.</p>\",\"PeriodicalId\":8401,\"journal\":{\"name\":\"Arteriosclerosis, Thrombosis, and Vascular Biology\",\"volume\":\" \",\"pages\":\"\"},\"PeriodicalIF\":8.8000,\"publicationDate\":\"2026-10-15\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Arteriosclerosis, Thrombosis, and Vascular Biology\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://doi.org/10.1161/ATVBAHA.126.324762\",\"RegionNum\":1,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q1\",\"JCRName\":\"HEMATOLOGY\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Arteriosclerosis, Thrombosis, and Vascular Biology","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1161/ATVBAHA.126.324762","RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"HEMATOLOGY","Score":null,"Total":0}
引用次数: 0

摘要

心血管成像在心血管疾病的诊断、风险分层和管理中发挥着核心作用,然而成像数据的复杂性和数量日益超过传统解释的能力。人工智能(AI)和深度学习为从常规心血管图像中提取定量、预后和表型信息提供了新的工具。本文总结了人工智能和深度学习的基础知识,包括模型架构、训练策略及其与心血管成像的相关性,随后重点讨论了当前在胸部x线摄影、胸部计算机断层扫描、计算机断层扫描血管成像/心脏计算机断层扫描、心脏磁共振成像、超声心动图和核心脏病成像方面的应用。研究的选择重点是原始调查、大型队列分析和外部验证研究,这些研究反映了人工智能在心血管风险分层和精确表型中的当前应用。在这些模式中,人工智能在自动图像处理和分析中的应用已经相对成熟。多个多中心和现实世界的研究已经证实了它们在提高效率和支持心血管管理方面的价值。超越传统的人类定义的成像指标来推断心血管风险和疾病表型的方法仍处于早期阶段,需要进一步的标准化、验证和临床评估。人工智能正在将心血管成像的作用从视觉解释扩展到风险分层和精确表型的综合评估,尽管在这些工具能够指导个体患者管理之前,还需要进一步的工作来确认其普遍性和实际表现。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
AI and Deep Learning in Cardiovascular Imaging: From Risk Stratification to Precision Phenotyping.

Cardiovascular imaging plays a central role in the diagnosis, risk stratification, and management of cardiovascular disease, yet the complexity and volume of imaging data increasingly exceed the capacity of conventional interpretation. Artificial intelligence (AI) and deep learning offer new tools to extract quantitative, prognostic, and phenotypic information from routine cardiovascular images. This review summarizes the fundamentals of AI and deep learning, including model architectures, training strategies, and their relevance to cardiovascular imaging, followed by a focused discussion of current applications across chest radiography, chest computed tomography, computed tomography angiography/cardiac computed tomography, cardiac magnetic resonance imaging, echocardiography, and nuclear cardiology imaging. Studies were selected with emphasis on original investigations, large cohort analyses, and external validation studies reflecting current applications of AI in cardiovascular risk stratification and precision phenotyping. Across these modalities, AI applications in automated image processing and analysis have become relatively mature. Multiple multicenter and real-world studies have validated their value in improving efficiency and supporting cardiovascular management. Approaches that move beyond conventional human-defined imaging metrics to infer cardiovascular risk and disease phenotype remain at an earlier stage, requiring further standardization, validation, and clinical evaluation. AI is expanding the role of cardiovascular imaging from visual interpretation toward integrated assessment for risk stratification and precision phenotyping, though further work is needed to confirm generalizability and real-world performance before these tools can guide individual patient management.

求助全文
通过发布文献求助,成功后即可免费获取论文全文。 去求助
来源期刊
CiteScore
15.60
自引率
2.30%
发文量
337
审稿时长
2-4 weeks
期刊介绍: The journal "Arteriosclerosis, Thrombosis, and Vascular Biology" (ATVB) is a scientific publication that focuses on the fields of vascular biology, atherosclerosis, and thrombosis. It is a peer-reviewed journal that publishes original research articles, reviews, and other scholarly content related to these areas. The journal is published by the American Heart Association (AHA) and the American Stroke Association (ASA). The journal was published bi-monthly until January 1992, after which it transitioned to a monthly publication schedule. The journal is aimed at a professional audience, including academic cardiologists, vascular biologists, physiologists, pharmacologists and hematologists.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信
小红书